199 related articles for article (PubMed ID: 33167868)
1. Egr-1 mediates low-dose arecoline induced human oral mucosa fibroblast proliferation via transactivation of Wnt5a expression.
Chen Q; Jiao J; Wang Y; Mai Z; Ren J; He S; Li X; Chen Z
BMC Mol Cell Biol; 2020 Nov; 21(1):80. PubMed ID: 33167868
[TBL] [Abstract][Full Text] [Related]
2. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
3. Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
Hsieh YP; Chen HM; Chang JZ; Chiang CP; Deng YT; Kuo MY
Head Neck; 2015 Apr; 37(4):493-7. PubMed ID: 24436257
[TBL] [Abstract][Full Text] [Related]
4. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
6. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
Khan I; Kumar N; Pant I; Narra S; Kondaiah P
PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
[TBL] [Abstract][Full Text] [Related]
7. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chou MY; Chang YC
Oral Oncol; 2003 Jun; 39(4):367-72. PubMed ID: 12676256
[TBL] [Abstract][Full Text] [Related]
8. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
Chang YC; Tsai CH; Tai KW; Yang SH; Chou MY; Lii CK
Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
[TBL] [Abstract][Full Text] [Related]
9. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
Tsai CH; Chou MY; Chang YC
J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
[TBL] [Abstract][Full Text] [Related]
10. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
11. Growth of oral and skin fibroblasts from patients with oral submucous fibrosis.
van Wyk CW; Olivier A; Hoal-van Helden EG; Grobler-Rabie AF
J Oral Pathol Med; 1995 Sep; 24(8):349-53. PubMed ID: 7500290
[TBL] [Abstract][Full Text] [Related]
12. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.
Chen CC; Huang JF; Tsai CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):604-14. PubMed ID: 7490793
[TBL] [Abstract][Full Text] [Related]
13. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
[TBL] [Abstract][Full Text] [Related]
15. The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline.
Yang SF; Tsai CH; Chang YC
J Oral Pathol Med; 2008 Apr; 37(4):206-10. PubMed ID: 18221324
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis.
Tsai CC; Ma RH; Shieh TY
J Oral Pathol Med; 1999 Feb; 28(2):59-63. PubMed ID: 9950251
[TBL] [Abstract][Full Text] [Related]
17. Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.
Zhang L; Tan J; Liu Y; Luo M
Oral Dis; 2024 May; 30(4):2314-2324. PubMed ID: 37382472
[TBL] [Abstract][Full Text] [Related]
18. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts.
Hsieh YP; Chen HM; Lin HY; Yang H; Chang JZ
J Formos Med Assoc; 2017 Feb; 116(2):107-113. PubMed ID: 26922429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
